Wednesday, July 8, 2026

Drug profile · INN

oxytocin

oxytocin (OXYTOCIN) is a oxytocin receptor agonist. Route of administration: injection. Current US regulatory status: approved.

FDA: approved NMPA: clinical trials
US status approved
Patents linked 7
Pipeline programs 31
News articles 0
Drug details — oxytocin
US status
approved
Class
Route
INJECTION
Patents
7
Programs
31
Data quality
0.84

Quick answer

oxytocin (OXYTOCIN) is a oxytocin receptor agonist. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN oxytocin
Brand OXYTOCIN
Mechanism Oxytocin receptor agonist
Target Oxytocin receptor
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Oxytocin receptor agonist

Primary target: Oxytocin receptor

Approval history

Authority Status Date
FDA approved
NMPA clinical trials

Pipeline programs

  1. 1. Intranasal oxytocin spray Phase 2 · United Therapeutics Europe · Autism Spectrum Disorder
  2. Intranasal Oxytocin Phase 2 · United Therapeutics Europe · Autism Spectrum Disorder
  3. OXY-APS Phase 2 · George Institute for · schizophrenia or other primary psychotic disorders (SSD)
  4. Oxytocin Phase 2 · United Therapeutics Europe · Alcohol Use Disorder
  5. Oxytocin Phase 2 · BRIGHT MINDS BIOSCIENCES · Social Cognition
  6. Oxytocin nasal spray Phase 2 · Cognition Therapeutics · Cold Exposure
  7. Oxytocin nasal spray Phase 2 · Cognition Therapeutics · Oxidative Stress
  8. 2017-004466-98 Phase 1 · Tonix Pharmaceuticals Holding · Pain, Face

Related & competitor drugs

  1. atosiban Genito-urinary system and sex hormones (G02)

Related patents

  1. US 12156897

    Magnesium-containing oxytocin formulations and methods of use

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 11970554

    Labeled oxytocin and method of manufacture and use

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 11389473

    Magnesium-containing oxytocin formulations and methods of use

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 10314885

    Oxytocin treatment to modify blood glucose and treat metabolic disease

    Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 9585935

    Intranasal oxytocin treatment to improve schizophrenia

    Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 6894026

    Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders

    Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  7. US 6333313

    Clinical use of oxytocin alone or in combination to treat bone disorders

    Expires Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is oxytocin?

oxytocin (OXYTOCIN) is a oxytocin receptor agonist. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for oxytocin?

OXYTOCIN is a marketed brand name for oxytocin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of oxytocin?

oxytocin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.